Urethral cancer surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
* [[Surgery]] is the mainstay of [[therapy]] for [[urethral]] [[cancers]] in both [[Women's College Hospital|women]] and [[men]]. The surgical approach depends on [[tumor]] stage and anatomic location, and tumor grade plays a less important role in treatment decisions. Although the traditional recommendation has been to achieve a 2-cm tumor-free margin, the optimal surgical margin has not been rigorously studied and is not well defined.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | * [[Surgery]] is the mainstay of [[therapy]] for [[urethral]] [[cancers]] in both [[Women's College Hospital|women]] and [[men]]. The surgical approach depends on [[tumor]] stage and anatomic location, and [[tumor]] [[Grade 1 (partial) Collaterals|grade]] plays a less important role in [[Treatment-resistant depression|treatment]] decisions. Although the traditional recommendation has been to achieve a 2-cm tumor-free margin, the optimal surgical margin has not been rigorously studied and is not well defined.<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> | ||
* The role of [[lymph node]] [[dissection]] is not clear in the absence of clinical involvement, and the role of prophylactic dissection is controversial. | * The role of [[lymph node]] [[dissection]] is not clear in the absence of clinical involvement, and the role of prophylactic dissection is controversial. | ||
* Ablative techniques, such as [[transurethral resection]], electroresection and fulguration, or laser vaporization-coagulation, are used to preserve organ function in cases of superficial anterior tumors, although the supporting literature is scant. | * Ablative techniques, such as [[transurethral resection]], electroresection and fulguration, or laser vaporization-coagulation, are used to preserve organ function in cases of superficial anterior tumors, although the supporting literature is scant. | ||
Revision as of 10:22, 22 June 2018
|
Urethral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urethral cancer surgery On the Web |
|
American Roentgen Ray Society Images of Urethral cancer surgery |
|
Risk calculators and risk factors for Urethral cancer surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Surgery is the mainstay of treatment for urethral cancer. However, it is not recommended among patients with metastatic urethral cancer.
Surgery
- Surgery is the mainstay of therapy for urethral cancers in both women and men. The surgical approach depends on tumor stage and anatomic location, and tumor grade plays a less important role in treatment decisions. Although the traditional recommendation has been to achieve a 2-cm tumor-free margin, the optimal surgical margin has not been rigorously studied and is not well defined.[1]
- The role of lymph node dissection is not clear in the absence of clinical involvement, and the role of prophylactic dissection is controversial.
- Ablative techniques, such as transurethral resection, electroresection and fulguration, or laser vaporization-coagulation, are used to preserve organ function in cases of superficial anterior tumors, although the supporting literature is scant.
- Surgery is the most common treatment for cancer of the urethra. One of the following types of surgery may be done:
- Surgery is not recommended among patients with metastatic urethral cancer.
References
- ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq